Ironwood Pharmaceuticals, Inc. (IRWD) Financials
IRWD Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 471.1 million | 817.4 million |
2023-09-30 | 524.1 million | 849.7 million |
2023-06-30 | 603.2 million | 950.0 million |
2023-03-31 | 1.2 billion | 448.4 million |
IRWD Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 35.6 million | 8.7 million |
2023-09-30 | 32.4 million | 7.9 million |
2023-06-30 | 35.0 million | 8.3 million |
2023-03-31 | 80.2 million | 7.1 million |
IRWD Net Income
No data available :(
IRWD Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 92.2 million | - | 17.7 million |
2023-09-30 | 110.2 million | - | 18.2 million |
2023-06-30 | 175.3 million | 598.0 million | 18.7 million |
2023-03-31 | 740.3 million | 396.7 million | 19.2 million |
IRWD Shares Outstanding
IRWD Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 211000 | 35.1 million | 38.7 million | - |
2023-09-30 | 49000 | 33.0 million | 36.0 million | - |
2023-06-30 | - | 1.1 billion | 52.5 million | - |
2023-03-31 | 13000 | 12.8 million | 31.1 million | - |
IRWD Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 117.6 million | 512000 |
2023-09-30 | 113.7 million | 507000 |
2023-06-30 | 107.4 million | 270000 |
2023-03-31 | 104.1 million | 286000 |
IRWD
Price: $8.12
52 week price:
Earnings Per Share: -6.45 USD
P/E Ratio: -2.43
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 405820
Ebitda: 26.2 millionMarket Capitalization: 1.2 billion